CAPRICOR THERAPEUTICS, INC. Increase (Decrease) in Accrued Interest Receivable, Net
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Increase (Decrease) in Accrued Interest Receivable, Net of $636 for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2014-11-14
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2014-09-30 was $593.00.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2014-06-30 was -$527.00.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2014-03-31 was $570.00.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for the quarter ending 2013-12-31 was -$3.24K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2013 was -$25.03K, a 199.26% decline from fiscal 2012.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in accrued interest receivable, net for fiscal 2012 was $25.21K.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month | Increase (Decrease) in Accrued Interest Receivable, Net 9 month | Increase (Decrease) in Accrued Interest Receivable, Net 12 month | Increase (Decrease) in Accrued Interest Receivable, Net 102 month | Increase (Decrease) in Accrued Interest Receivable, Net 105 month |
|---|---|---|---|---|---|---|
| 2014-09-30 | $593.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $66.00 derived: sum of 2 quarters · filed 2014-11-14 | $636.00 10-Q · filed 2014-11-14 | -$2.60K derived: sum of 4 quarters · filed 2014-11-14 | ||
| 2014-06-30 | -$527.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $43.00 10-Q · filed 2014-08-14 | -$3.20K derived: sum of 3 quarters · filed 2014-08-14 | -$14.49K derived: sum of 4 quarters · filed 2014-11-14 | ||
| 2014-03-31 | $570.00 10-Q · filed 2014-05-15 | -$2.67K derived: sum of 2 quarters · filed 2014-05-15 | -$13.96K derived: sum of 3 quarters · filed 2014-11-14 | -$16.18K derived: sum of 4 quarters · filed 2014-11-14 | $757.00 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$3.24K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$14.53K derived: sum of 2 quarters · filed 2014-11-14 | -$16.75K derived: sum of 3 quarters · filed 2014-11-14 | -$25.03K 10-K · filed 2014-03-31 | $187.00 10-K · filed 2014-03-31 | |
| 2013-09-30 | -$11.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$13.51K derived: sum of 2 quarters · filed 2014-11-14 | -$21.79K 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | -$2.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$10.50K 10-Q · filed 2014-08-14 | ||||
| 2013-03-31 | -$8.27K 10-Q · filed 2014-05-15 | |||||
| 2012-12-31 | $25.21K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |